Viewing Study NCT00065351


Ignite Creation Date: 2025-12-24 @ 11:44 PM
Ignite Modification Date: 2025-12-25 @ 9:36 PM
Study NCT ID: NCT00065351
Status: COMPLETED
Last Update Posted: 2019-11-12
First Post: 2003-07-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety and Efficacy of Single-agent CC-5013 in Subjects With Relapsed and Refractory Multiple Myeloma
Sponsor: Celgene
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Multiple Myeloma View
None CC-5013 View
None Revlimid View
None MM View
None CC5013 View
None relapsed and refractory multiple myeloma View